Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Patient Education on Oral Anticoagulation.

Hawes EM.

Pharmacy (Basel). 2018 Apr 20;6(2). pii: E34. doi: 10.3390/pharmacy6020034.

2.

Implementation and evaluation of a pharmacist-led electronic visit program for diabetes and anticoagulation care in a patient-centered medical home.

Hawes EM, Lambert E, Reid A, Tong G, Gwynne M.

Am J Health Syst Pharm. 2018 Jun 15;75(12):901-910. doi: 10.2146/ajhp170174. Epub 2018 Apr 13.

PMID:
29654139
3.

Post-Hospital Discharge Care: A Retrospective Cohort Study Exploring the Value of Pharmacist-Enhanced Care and Describing Medication-Related Problems.

Hawes EM, Pinelli NR, Sanders KA, Lipshutz AM, Tong G, Sievers LS, Chao S, Gwynne M.

N C Med J. 2018 Jan-Feb;79(1):4-13. doi: 10.18043/ncm.79.1.4.

4.

Latent autoimmune diabetes of adulthood: case report.

Page CP, Fitzgerald B, Hawes EM.

Clin Diabetes Endocrinol. 2017 Nov 28;3:11. doi: 10.1186/s40842-017-0049-9. eCollection 2017.

5.

Accountable Care in Transitions (ACTion): A Team-Based Approach to Reducing Hospital Utilization in a Patient-Centered Medical Home.

Hawes EM, Smith JN, Pinelli NR, Adams R, Tong G, Weir S, Gwynne M.

J Pharm Pract. 2018 Apr;31(2):175-182. doi: 10.1177/0897190017707118. Epub 2017 May 3.

PMID:
28468524
6.

Management of mild hypertension in adults.

Viera AJ, Hawes EM.

BMJ. 2016 Nov 21;355:i5719. doi: 10.1136/bmj.i5719. Review.

PMID:
27872051
7.

Prescribing pharmacists in the ambulatory care setting: Experience at the University of North Carolina Medical Center.

Hawes EM, Misita C, Burkhart JI, McKnight L, Deyo ZM, Lee RA, Howard C, Eckel SF.

Am J Health Syst Pharm. 2016 Sep 15;73(18):1425-33. doi: 10.2146/ajhp150771.

PMID:
27605321
8.

Probable glucometer interference caused by topical iodine solution test site preparation.

Lipshutz AM, Hawes EM.

J Clin Pharm Ther. 2016 Oct;41(5):583-5. doi: 10.1111/jcpt.12431. Epub 2016 Aug 8.

PMID:
27500356
9.

What next when metformin isn't enough for type 2 diabetes?

Hawes EM, Wehby J, Mounsey A.

J Fam Pract. 2016 Feb;65(2):85-9. Review.

PMID:
26977458
10.

Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?

Gosselin RC, Francart SJ, Hawes EM, Moll S, Dager WE, Adcock DM.

Ann Pharmacother. 2015 Jul;49(7):777-83. doi: 10.1177/1060028015578451. Epub 2015 Apr 8.

PMID:
25855705
11.

Diagnosis and management of acute coronary syndrome: an evidence-based update.

Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ.

J Am Board Fam Med. 2015 Mar-Apr;28(2):283-93. doi: 10.3122/jabfm.2015.02.140189. Review.

12.

Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban.

Gosselin RC, Adcock Funk DM, Taylor JM, Francart SJ, Hawes EM, Friedman KD, Moll S.

Arch Pathol Lab Med. 2014 Dec;138(12):1680-4. doi: 10.5858/arpa.2013-0750-OA.

PMID:
25427046
13.

Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban.

Gosselin RC, Adcock D, Hawes EM, Francart SJ, Grant RP, Moll S.

Thromb Haemost. 2015 Jan;113(1):77-84. doi: 10.1160/TH14-04-0361. Epub 2014 Nov 20.

PMID:
25413383
14.

Adverse events associated with metal contamination of traditional chinese medicines in Korea: a clinical review.

Kim H, Hughes PJ, Hawes EM.

Yonsei Med J. 2014 Sep;55(5):1177-86. doi: 10.3349/ymj.2014.55.5.1177. Review.

15.

Anticoagulation: managing adverse events in patients receiving anticoagulation and perioperative care.

Hawes EM, Viera AJ.

FP Essent. 2014 Jul;422:31-9; quiz 40-3. Review.

PMID:
25033004
16.

Anticoagulation: monitoring of patients receiving anticoagulation.

Hawes EM, Viera AJ.

FP Essent. 2014 Jul;422:24-30. Review.

PMID:
25033003
17.

Anticoagulation: choosing the optimal anticoagulant.

Hawes EM, Viera AJ.

FP Essent. 2014 Jul;422:18-23. Review.

PMID:
25033002
18.

Anticoagulation: indications and risk classification schemes.

Hawes EM, Viera AJ.

FP Essent. 2014 Jul;422:11-7. Review.

PMID:
25033001
19.

Clinically relevant interaction between warfarin and scuppernongs, a quercetin containing muscadine grape: continued questions surrounding flavonoid-induced warfarin interactions.

Woodward CJ, Deyo ZM, Donahue KE, Deal AM, Hawes EM.

BMJ Case Rep. 2014 Jun 25;2014. pii: bcr2013009608. doi: 10.1136/bcr-2013-009608.

20.

Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.

Francart SJ, Hawes EM, Deal AM, Adcock DM, Gosselin R, Jeanneret C, Friedman KD, Moll S.

Thromb Haemost. 2014 Jun;111(6):1133-40. doi: 10.1160/TH13-10-0871. Epub 2014 Jan 9.

PMID:
24401946
21.

Impact of an outpatient pharmacist intervention on medication discrepancies and health care resource utilization in posthospitalization care transitions.

Hawes EM, Maxwell WD, White SF, Mangun J, Lin FC.

J Prim Care Community Health. 2014 Jan 1;5(1):14-8. doi: 10.1177/2150131913502489. Epub 2013 Sep 17.

PMID:
24327590
22.

Haemolytic anaemia after ingestion of Neem (Azadirachta indica) tea.

Page C, Hawes EM.

BMJ Case Rep. 2013 Oct 17;2013. pii: bcr2013200890. doi: 10.1136/bcr-2013-200890.

23.

Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels.

Hawes EM, Deal AM, Funk-Adcock D, Gosselin R, Jeanneret C, Cook AM, Taylor JM, Whinna HC, Winkler AM, Moll S.

J Thromb Haemost. 2013 Aug;11(8):1493-502. doi: 10.1111/jth.12308.

24.

In vitro identification of the human cytochrome p450 enzymes involved in the oxidative metabolism of loxapine.

Luo JP, Vashishtha SC, Hawes EM, McKay G, Midha KK, Fang J.

Biopharm Drug Dispos. 2011 Oct;32(7):398-407. doi: 10.1002/bdd.768. Epub 2011 Aug 9.

PMID:
21826677
26.
28.
29.
31.
33.

Characterization of two structural forms of otonecine-type pyrrolizidine alkaloids from Ligularia hodgsonii by NMR spectroscopy.

Lin G, Rose P, Chatson KB, Hawes EM, Zhao XG, Wang ZT.

J Nat Prod. 2000 Jun;63(6):857-60.

PMID:
10869221
35.

Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine.

Tugnait M, Hawes EM, McKay G, Eichelbaum M, Midha KK.

Chem Biol Interact. 1999 Apr 1;118(2):171-89.

PMID:
10359460
36.
38.

N-oxygenation of clozapine by flavin-containing monooxygenase.

Tugnait M, Hawes EM, McKay G, Rettie AE, Haining RL, Midha KK.

Drug Metab Dispos. 1997 Apr;25(4):524-7.

PMID:
9107553
39.

Identification of lactams as in vitro metabolites of piperidine-type phenothiazine antipsychotic drugs.

Lin G, Chu KW, Damani LA, Hawes EM, Midha KK.

J Pharm Biomed Anal. 1996 Apr;14(6):727-38. Erratum in: J Pharm Biomed Anal 1997 Mar;15(6):855. J Pharm Biomed Anal 1997 Sep;16(1):181.

PMID:
8807548
40.

Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine.

Muralidharan G, Cooper JK, Hawes EM, Korchinski ED, Midha KK.

Eur J Clin Pharmacol. 1996;50(1-2):121-8.

PMID:
8739822
41.

Evidence for the lack of a human metabolic isotope effect of a deuterium analog of fluphenazine.

Hadad S, Hubbard JW, McKay G, Hawes EM, Shrikhande S, Midha KK.

Pharm Res. 1995 Sep;12(9):1388-90. No abstract available.

PMID:
8570541
42.

N(+)-glucuronidation of aliphatic tertiary amines in human: antidepressant versus antipsychotic drugs.

Luo H, Hawes EM, McKay G, Korchinski ED, Midha KK.

Xenobiotica. 1995 Mar;25(3):291-301.

PMID:
7618355
43.
44.

Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implications.

Hubbard JW, Midha KK, Hawes EM, McKay G, Marder SR, Aravagiri M, Korchinski ED.

Br J Psychiatry Suppl. 1993 Dec;(22):19-24. Review.

PMID:
7906521
46.

Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat.

Lin G, Hawes EM, McKay G, Korchinski ED, Midha KK.

Xenobiotica. 1993 Oct;23(10):1059-74.

PMID:
8259689
47.

Clinical perspectives of some neuroleptics through development and application of their assays.

Midha KK, Marder SR, Jaworski TJ, McKay G, Hubbard JW, Hawes EM, Van Putten T, Wirshing WC, Aravagiri M.

Ther Drug Monit. 1993 Jun;15(3):179-89. Review.

PMID:
8101398
48.

The role of metabolites in a bioequivalence study 1: loxapine, 7-hydroxyloxapine and 8-hydroxyloxapine.

Midha KK, Hubbard JW, McKay G, Hawes EM, Hsia D.

Int J Clin Pharmacol Ther Toxicol. 1993 Apr;31(4):177-83.

PMID:
8500919
49.

Synthesis of the N-oxides of phenothiazine antipsychotic agents.

Jaworski TJ, Sardessai MS, Aravagiri M, Lin G, Shi YY, Hawes EM, Hubbard JW, McKay G, Midha KK.

J Pharm Sci. 1993 Mar;82(3):330-3.

PMID:
8095544
50.

Logarithmic transformation in bioequivalence: application with two formulations of perphenazine.

Midha KK, Ormsby ED, Hubbard JW, McKay G, Hawes EM, Gavalas L, McGilveray IJ.

J Pharm Sci. 1993 Feb;82(2):138-44. Erratum in: J Pharm Sci 1993 Dec;82(12):1300.

PMID:
8445525

Supplemental Content

Loading ...
Support Center